• Intervention
  • While treatment with antithrombotic or fibrinolytic agents and other agents has been attempted with variable success in hepatic SOS after stem cell transplantation [ 5 , 6 ], the efficacy of pharmacological intervention has not been systematically studied in dactinomycin-induced SOS. (jcancer.org)
  • Cancer
  • The amount of dactinomycin that you will receive depends on many factors, including your height and weight, your general health or other health problems, and the type of cancer or condition being treated. (chemocare.com)
  • There is a slight risk of developing a secondary cancer months to years after taking dactinomycin. (chemocare.com)
  • Using dactinomycin may increase your risk of developing other types of cancer, such as leukemia. (wellspan.org)
  • Dactinomycin is also a form of antibiotic which is useful in treating children related / pediatric forms of cancer. (medicalrealm.net)